Company profile for Alkido Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The AIkido Pharma Inc. platform contains patented technology from leading universities and researchers and we seek to develop our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University. Our diverse pipeline of...
AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The AIkido Pharma Inc. platform contains patented technology from leading universities and researchers and we seek to develop our innovative drugs through strong partnership with world renowned institutions, such as The University of Texas and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Rockefeller Plaza 11th Floor New York, NY 10020
Telephone
Telephone
(703) 992-9325
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmacompass.com/pdf/news/aikido-pharma-files-patent-application-for-the-use-of-ketamine-1626764742.pdf

PRNEWSWIRE
23 Jun 2021

https://www.prnewswire.com/news-releases/aikido-pharma-notes-advancement-in-radiopharmaceutical-research-301270638.html

PRNEWSWIRE
16 Apr 2021

https://www.prnewswire.com/news-releases/aikido-granted-sublicense-to-technology-for-targeted-psilocybin-treatment-of-neuro-inflamed-tissue-in-cancer-patients-301264075.html

PRNEWSWIRE
07 Apr 2021

https://www.prnewswire.com/news-releases/aikido-pharma-sponsors-psychedelic-compound-research-to-treat-ptsd-301257485.html

PRNEWSWIRE
29 Mar 2021

https://www.prnewswire.com/news-releases/aikido-pharma-inc-to-present-at-the-hc-wainwright-global-life-sciences-conference-virtual-event-301237346.html

PRNEWSWIRE
01 Mar 2021

https://www.prnewswire.com/news-releases/aikido-pharma-provides-update-on-its-antiviral-platform-including-the-virus-that-causes-covid-19-301231899.html

PRNEWSWIRE
22 Feb 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty